drugset

drugset / Trial / NCT01119339

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

NCT01119339 ↗

Phase 2 Completed 20 enrolled Almirall, S.A.

RandomizedFactorialSingle-blindTreatment

Summary

The aim of the study is to intra-individually compare the dose-related efficacy of LAS41004 in a Psoriasis Plaque Test (PPT)

Timeline

Start: 2010-07
Primary completion: 2010-09
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LAS41004	Unknown	—	—

Indications